Real-world Evidence on the Use of Daratumumab, Bortezomib and Dexamethasone (dvd) in Lenalidomide-Refractory Myeloma Patients: Subgroup Analysis of the Multicenter Retrospective Experience by “rete Ematologica Pugliese”